Yogini Raste
- Validity of physical activity monitors during daily life in patients with COPDBy Roberto A. Rabinovich, Zafeiris Louvaris, Yogini Raste, Daniel Langer, Hans Van Remoortel, Santiago Giavedoni, Chris Burtin, Eloisa M.G. Regueiro, Ioannis Vogiatzis, Nicholas S. Hopkinson, Michael I. Polkey, Frederick J. Wilson, William MacNee, Klaas R. Westerterp and Thierry TroostersRoberto A. Rabinovich1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh8Both authors contributed equallyZafeiris Louvaris2Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece8Both authors contributed equallyYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonDaniel Langer4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumHans Van Remoortel4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumSantiago Giavedoni1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, EdinburghChris Burtin4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumEloisa M.G. Regueiro5Laboratory of Respiratory Physiotherapy, Universidade Federal de São Carlos (UFSCar), São Carlos, BrazilIoannis Vogiatzis2Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceNicholas S. Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonMichael I. Polkey3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonFrederick J. Wilson6Precision Medicine, Pfizer Worldwide Research and Development, Sandwich, UKWilliam MacNee1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, EdinburghKlaas R. Westerterp7Dept of Human Biology, Maastricht University, Maastricht, The NetherlandsThierry Troosters4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- Activity outcomes correlation of 6 monitors in COPD, a field study part of the PROactive projectBy Santiago Giavedoni, Roberto Rabinovich, Yogini Raste, Nicholas Hopkinson, Hans Van Remoortel, Eloisa M. Gatti Regueiro, Daniel Langer, Zafiris Louvaris, Ioannis Vogiatzis, Barry Peterson, Frederick Wilson and Thierry TroostersSantiago Giavedoni1Respiratory Medicine, ELEGI Colt Laboratories, CIR, The University of Edinburgh, Edinburgh, United KingdomRoberto Rabinovich1Respiratory Medicine, ELEGI Colt Laboratories, CIR, The University of Edinburgh, Edinburgh, United KingdomYogini Raste2Respiratory Muscle Laboratory, Royal Brompton Hospital, London, United KingdomNicholas Hopkinson2Respiratory Muscle Laboratory, Royal Brompton Hospital, London, United KingdomHans Van Remoortel3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumEloisa M. Gatti RegueiroDaniel Langer3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumZafiris Louvaris5Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceIoannis Vogiatzis5Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceBarry Peterson6Pfizer Global Research and Development, Pfizer, Sandwich, Kent, United KingdomFrederick Wilson6Pfizer Global Research and Development, Pfizer, Sandwich, Kent, United KingdomThierry Troosters3Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive projectBy Zafeiris Louvaris, Daniel Langer, Santiago Giavedoni, Yogini Raste, Hans Van Remoortel, Eloisa Maria Gatti Regueiro, Frederick Wilson, Ioannis Vogiatzis, Nicholas Hopkinson, Roberto Rabinovich, Barry Peterson and Thierry TroostersZafeiris LouvarisDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomDaniel LangerDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomSantiago GiavedoniDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomYogini RasteDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomHans Van RemoortelDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomEloisa Maria Gatti RegueiroDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomFrederick WilsonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomIoannis VogiatzisDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomNicholas HopkinsonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomRoberto RabinovichDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomBarry PetersonDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United KingdomThierry TroostersDepartment of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
- Validity of 6 activity monitors during standard physical activities in COPD – Comparison with indirect calorimetryBy Yogini Raste, Daniel Langer, Chris Burtin, Zafiris Louvaris, Santiago Giavedoni, Francesco Costa, Frederick Wilson, Roberto Rabinovich, Nicholas Hopkinson, Ioannis Vogiatzis, Barry Peterson and Thierry TroostersYogini Raste1Respiratory Medicine, NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, United KingdomDaniel Langer2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, BelgiumChris Burtin2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, BelgiumZafiris Louvaris3Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceSantiago Giavedoni4ELEGI Colt Laboratories, Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomFrancesco Costa5Section of Pneumology, University of Pisa, Pisa, ItalyFrederick Wilson6Molecular Medicine, Physiological Measurements, Pfizer Worldwide Research and Development, Sandwich, Kent, United KingdomRoberto Rabinovich4ELEGI Colt Laboratories, Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomNicholas Hopkinson1Respiratory Medicine, NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, United KingdomIoannis Vogiatzis3Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceBarry Peterson7Molecular Medicine, Physiological Measurements, Pfizer Worldwide Research and Development, Groton, CT, United StatesThierry Troosters2Faculty of Kinesiology and Rehabilitation Science, KU Leuven, Leuven, Belgium
- Validity of activity monitors for physical activity assessment in patients with chronic obstructive pulmonary diseaseBy Roberto Rabinovich, Zafeiris Louvaris, Yogini Raste, Daniel Langer, Hans Van Remoortel, Santiago Giavedoni, Chris Burtin, Eloisa Regueiro, Ioannis Vogiatzis, Nicholas Hopkinson, Michael Polkey, Frederik Wilson, William MacNee, Klass Westerterp and Thierry TroostersRoberto Rabinovich1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomZafeiris Louvaris2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian, University of Athens, GreeceYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomDaniel Langer4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumHans Van Remoortel4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumSantiago Giavedoni1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomChris Burtin4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, BelgiumEloisa Regueiro5UFSCar, São Carlos, Universidade Federal de São Carlos, BrazilIoannis Vogiatzis2Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian, University of Athens, GreeceNicholas Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomMichael Polkey3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomFrederik Wilson6Precision Medicine, Pfizer Worldwide Research and Development, Pfizer, Kent, United KingdomWilliam MacNee1ELEGI Colt Laboratory, Centre for Inflammation Research, the Queen's Medical Research Institute, The University of Edinburgh, Scotland, United KingdomKlass Westerterp7Department of Human Biology, Maastricht University, Maastricht, NetherlandsThierry Troosters4Faculty of Kinesiology and Rehabilitation Sciences, Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Belgium
- Agreement of classification of COPD patients' physical activity with two activity monitorsBy Heleen Demeyer, Roberto Rabinovich, Susan Loh, Yogini Raste, Nick Hopkinson, Zafiris Louvaris, Iannis Vogiatzis, Corina De Jong, Tys Van der Molen, Elena Gimeno-Santos, Solange Rohou, Damijan Erzen, Karoly Kulich, Niklas Karlsson, Thierry Troosters and Judith Garcia AymerichHeleen Demeyer1Department of Rehabilitation Sciences, KULeuven, Leuven, BelgiumRoberto Rabinovich2ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, Scotland, United KingdomSusan Loh2ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, Scotland, United KingdomYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomNick Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomZafiris Louvaris4Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceIannis Vogiatzis4Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceCorina De Jong5Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsTys Van der Molen6Department of Primary Care, University of Groningen, UMCG, Groningen, NetherlandsElena Gimeno-Santos7Centre for Research in Environmental Epidemiology, CREAL, Barcelona, SpainSolange Rohou8R&D, Astra Zeneca, Mölndal, SwedenDamijan Erzen10Respiratory Diseases Research, Boehringer-Ingelheim, Ingelheim, GermanyKaroly Kulich9Respiratory, Novartis, Basel, SwitzerlandNiklas Karlsson8R&D, Astra Zeneca, Mölndal, SwedenThierry Troosters1Department of Rehabilitation Sciences, KULeuven, Leuven, BelgiumJudith Garcia Aymerich7Centre for Research in Environmental Epidemiology, CREAL, Barcelona, Spain
- Determinants and outcomes of physical activity in patients with COPDBy Elena Gimeno-Santos, Anja Frei, Jordi de Batlle, Claudia Steurer-Stey, Milo A. Puhan, Hans Van Remoortel, Thierry Troosters, Yogini Raste, Nicholas S. Hopkinson, Michael I. Polkey, Roberto A. Rabinovich, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainAnja Frei2Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandJordi de Batlle1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainClaudia Steurer-Stey3Institute of General Practice and Health Services Research, University Hospital of Zurich, Zurich, SwitzerlandMilo A. Puhan2Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandHans Van Remoortel4Department of Rehabilitation Sciences, Katholieke University of Leuven, Leuven, BelgiumThierry Troosters4Department of Rehabilitation Sciences, Katholieke University of Leuven, Leuven, BelgiumYogini Raste5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomNicholas S. Hopkinson5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomMichael I. Polkey5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomRoberto A. Rabinovich6ELEGI/Colt Laboratory UoE/MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomNiklas Karlsson7R&D, Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, Spain
- Patient reported outcomes for the measurement of physical activity in COPD patients. The PROactive toolsBy Elena Gimeno-Santos, Yogini Raste, Zafiris Louvaris, Corina de Jong, Heleen Demeyer, Roberto Rabinovich, Nicholas Hopkinson, Iannis Vogiatzis, Karoly Kulich, Damijan Erzen, Maggie Tabberer, Milo Puhan, Nathalie Ivanoff, Xavier Basagaña, Ignasi Serra, Pim de Boer, Fabienne Dobbels, Thys van der Molen, Michael Polkey, Thierry Troosters, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainYogini Raste2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomZafiris Louvaris3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceCorina de Jong4Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsHeleen Demeyer5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumRoberto Rabinovich6ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, the University of Edinburgh, Edinburgh, United KingdomNicholas Hopkinson2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomIannis Vogiatzis3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceKaroly Kulich7Respiratory Department, Novartis, Basel, SwitzerlandDamijan Erzen8Boehringer Ingelheim Pharma GmbH & Co., KG Clinical Research - Respiratory, Ingelheim am Rhein, GermanyMaggie Tabberer9Global Health Outcomes, GlaxoSmithKline, Brentford, United KingdomMilo Puhan10Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandNathalie Ivanoff11Respiratory Department, Almirall, Sant Feliu de Llobregat, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainIgnasi Serra1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainPim de Boer12Lung, Netherlands Asthma Foundation, Amersfoort, NetherlandsFabienne Dobbels13Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Leuven, BelgiumThys van der Molen14Department of Primary Care, University of Groningen, UMCG, Groningen, NetherlandsMichael Polkey2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomThierry Troosters5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumNiklas Karlsson15R&D, Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, Spain
- Validity of physical activity monitors during daily life in patients with COPDBy Roberto A Rabinovich, Zafeiris Louvaris, Yogini Raste, Daniel Langer, Hans Van Remoortel, Santiago Giavedoni, Chris Burtin, Eloisa M. G. Regueiro, Ioannis Vogiatzis, Nicholas S. Hopkinson, Michael I. Polkey, Frederick J. Wilson, William MacNee, Klaas R. Westerterp and Thierry TroostersArticle | Published in 2013 in European Respiratory JournalRoberto A Rabinovich*ELEGI Colt Laboratory, Centre for Inflammation Research. The Queen's Medical Research Institute, University of Edinburgh, Scotland, UK##These authors (RR and ZL) contributed equally to this workZafeiris Louvaris#Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, Greece##These authors (RR and ZL) contributed equally to this workYogini Raste¶NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomDaniel Langer+Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumHans Van Remoortel+Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumSantiago Giavedoni*ELEGI Colt Laboratory, Centre for Inflammation Research. The Queen's Medical Research Institute, University of Edinburgh, Scotland, UKChris Burtin+Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumEloisa M. G. Regueiro§Laboratory of Respiratory Physiotherapy, Universidade Federal de São Carlos - UFSCar, São Carlos, BrazilIoannis Vogiatzis#Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceNicholas S. Hopkinson¶NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomMichael I. Polkey¶NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomFrederick J. WilsonfPrecision Medicine, Pfizer Worldwide Research and Development, Sandwich, Kent, United KingdomWilliam MacNee*ELEGI Colt Laboratory, Centre for Inflammation Research. The Queen's Medical Research Institute, University of Edinburgh, Scotland, UKKlaas R. Westerterp**Dept of Human Biology, Maastricht University, Maastricht, the NetherlandsThierry Troosters+Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- Does a single Pseudomonas aeruginosa isolation predict COPD mortality?By Afroditi K. Boutou, Yogini Raste, Jeremy Reid, Khalid Alshafi, Michael I. Polkey and Nicholas S. HopkinsonArticle | Published in 2014 in European Respiratory JournalAfroditi K. Boutou1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKYogini Raste1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKJeremy Reid1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKKhalid Alshafi2Dept of Microbiology, Royal Brompton Hospital, London, UKMichael I. Polkey1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKNicholas S. Hopkinson1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK
- Does a single Pseudomonas aeruginosa isolation predict COPD mortality?By Afroditi K. Boutou, Yogini Raste, Jeremy Reid, Khalid Alshafi, Michael I. Polkey and Nicholas S. HopkinsonAfroditi K. Boutou1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKYogini Raste1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKJeremy Reid1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKKhalid Alshafi2Dept of Microbiology, Royal Brompton Hospital, London, UKMichael I. Polkey1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKNicholas S. Hopkinson1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.